Abstract:
Die vorliegende Erfindung betrifft ein Syntheseverfahren enthaltend die folgenden Schritte (i) Umsetzung von 3-Ethyl-4-nitrobenzoesäure mit Thionylchlorid zur Erzeugung eines 3-Ethyl-4-nitrobenzoesäurechlorids oder mittels Wasserabspaltung aus 3-Ethyl-4-nitrobenzoesäure eines 3-Ethyl-4-nitrobenzoesäureanhydrids und (ii) Friedel-Crafts-Acylierung durch Reaktion des 3-Ethyl-4-nitrobenzoesäurechlorids oder des 3-Ethyl-4-nitrobenzoesäureanhydrids mit gegebenenfalls substituiertem Aryl-H, so dass gegebenenfalls substituiertes (3-Ethyl-4-nitrophenyl)-aryl-methanon entsteht. Darüber hinaus betrifft die vorliegende Erfindung Verbindungen enthaltend (3-Ethyl-4-nitrophenyl)-aryl-methanon, dadurch gekennzeichnet, dass das gegebenenfalls substituierte Aryl ein gegebenenfalls substituierter kondensierter Aromat ist.
Abstract:
The invention provides fluorosulfonyl compounds having high polymerizability, a process for the preparation thereof, fluorosulfonyl-bearing polymerizable monomers derived from the compounds, polymers obtained by polymerizing the monomers, and polymers bearing sulfonic acid groups which are derived from the polymers. Compounds (5) are produced by fluorinating a compound (3) into a compound (4) and decomposing the compound (4). Compounds (7-1) having high polymerizability are produced by subjecting compounds (5-1), which are included among the compounds (5), to thermolysis. Polymers obtained by polymerizing compounds (7-1) are converted into polymers bearing sulfonic acid groups through alkaline hydrolysis. (3) (4) (5) (5-1) (7-1)
Abstract:
Compounds of formula (I) and the isomers, and isomer mixtures thereof, which are possible, in which either a) X is an N atom and Y is OR11 or N(R12)R13, or b) X is CH and Y is OR11, and in which furthermore: R11 is C1-C4alkyl; R12 and R13, independently, are hydrogen or C1-C4alkyl; A is an O atom or the group NR4; R1 is hydrogen, C1-C4alkyl, halo-C1-C4alkyl, cyclopropyl, cyano or methylthio; R2 is hydrogen, C1-C6alkyl, C3-C6cycloalkyl, a group (i), a group (ii), or thienyl; R3 is hydrogen, C1-C6alkyl, C1-C6haloalkyl having 1 to 5 halogen atoms, C1-C4alkoxy-C1-C2alkyl, C2-C4alkenyl-C1-C2alkyl, which is unsubstituted or substituted by 1 to 3 halogen atoms, C2-C4alkynyl-C1-C2-alkyl, C3-C6cycloalkyl which is unsubstituted or substituted by 1 to 4 halogen atoms, C3-C6-cycloalkyl-C1-C4alkyl which is unsubstituted or substituted by 1 to 4 halogen atoms, cyano-C1-C4alkyl; C1-C4alkoxycarbonyl-C1-C2alkyl, C1-C4alkoxycarbamoyl-C1-C2alkyl, phenyl-C1-C3alkyl which is unsubstituted or substituted by halogen, C1-C3alkyl, C1-C4alkoxy, C1-C4haloalkyl, cyano, nitro or C1-C4alkylenedioxy, it being possible for the phenyl group to be monosubstituted to trisubstituted by identical or different substituents; phenyl which is unsubstituted or mono- to disubstituted, independently, by C1-C4alkyl, C1-C4alkoxy, halogen, C1-C2haloalkyl having 1 to 3 halogen atoms, nitro or cyano, or pyridyl which is unsubstituted or mono- to disubstituted, independently, by C1-C4alkyl, C1-C4alkoxy, halogen, C1-C2haloalkyl having 1 to 3 halogen atoms, nitro or cyano; R4 is C1-C4alkyl, phenyl, or R3 and R4 together with the nitrogen atom to which they are bonded form a saturated or unsaturated 5- to 7-membered ring which is unsubstituted or substituted by C1-C4alkyl and which can have 1 to 3 additional hetero atoms selected from amongst N, O and S, and in which the substituents Z, B, D and n are as defined in the present publication, are pesticidal active ingredients. They can be used for pest control, in particular as microbicides, insecticides and acaricides in agriculture, horticulture and in the hygiene sector.
Abstract:
Die Erfindung betrifft ein Verfahren zur Herstellung von 2,7-Dimethyl-2,4,6-octatrienal-monoacetalen der allgemeinen Formel I dadurch gekennzeichnet, daß man
a) ein Esterphosphoniumsalz der allgemeinen Formel II oder ein Esterphosphonat der allgemeinen Formel III, mit einem Aldehyd der Formel IV in einer Wittig- oder Wittig-Horner-Reaktion zu einem Acetalester der allgemeinen Formel V kondensiert,
b) den Ester der Formel V zu einem Acetal-alkohol der allgemeinen Formel VI reduziert und c) den Alkohol zu 2,7-Dimethyl-2,4,6-octatrienal-monoacetalen der allgemeinen Formel I oxidiert, wobei die Substituenten die in der Beschreibung definierte Bedeutung haben.
Abstract:
A compound of formula (I) wherein R?1 and R2¿ are as defined in the description, R2 being an aromatic group, useful in the treatment and condition selected from the group consisting of the group meningitis and salpingitis, septic shock, disseminated intravascular coagulation, and/or adult respiratory distress syndrome, acute or chronic inflammation, arthritis, cholangitis, colitis, encephalitis, endocarditis, glomerulonephritis, hepatitis, myocarditis, pancreatitis, pericarditis, reperfusion injury, vasculitis, acute and delayed hypersensitivity, graft rejection, and graft-versus-host disease, auto-immune diseases including Type 1 diabetes mellitus and multiple sclerosis, periodonate diseases, interstitial pulmonary fibrosis, cirrhosis, systemic sclerosis, keloid formation tumors which produce IL-1 as an autocrine growth factor, cachexia, Alzeimer's disease, percussion injury, depression, atherosclerosis, osteoporosis in a mammal, including a human.
Abstract:
This invention relates to a novel class of sulfonamides that are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention.
Abstract:
Compounds of formula (I) and the isomers, and isomer mixtures thereof, which are possible, in which either a) X is an N atom and Y is OR11 or N(R12)R13, or b) X is CH and Y is OR11, and in which furthermore: R11 is C1-C4alkyl; R12 and R13, independently, are hydrogen or C1-C4alkyl; A is an O atom or the group NR4; R1 is hydrogen, C1-C4alkyl, halo-C1-C4alkyl, cyclopropyl, cyano or methylthio; R2 is hydrogen, C1-C6alkyl, C3-C6cycloalkyl, a group (i), a group (ii), or thienyl; R3 is hydrogen, C1-C6alkyl, C1-C6haloalkyl having 1 to 5 halogen atoms, C1-C4alkoxy-C1-C2alkyl, C2-C4alkenyl-C1-C2alkyl, which is unsubstituted or substituted by 1 to 3 halogen atoms, C2-C4alkynyl-C1-C2-alkyl, C3-C6cycloalkyl which is unsubstituted or substituted by 1 to 4 halogen atoms, C3-C6-cycloalkyl-C1-C4alkyl which is unsubstituted or substituted by 1 to 4 halogen atoms, cyano-C1-C4alkyl; C1-C4alkoxycarbonyl-C1-C2alkyl, C1-C4alkoxycarbamoyl-C1-C2alkyl, phenyl-C1-C3alkyl which is unsubstituted or substituted by halogen, C1-C3alkyl, C1-C4alkoxy, C1-C4haloalkyl, cyano, nitro or C1-C4alkylenedioxy, it being possible for the phenyl group to be monosubstituted to trisubstituted by identical or different substituents; phenyl which is unsubstituted or mono- to disubstituted, independently, by C1-C4alkyl, C1-C4alkoxy, halogen, C1-C2haloalkyl having 1 to 3 halogen atoms, nitro or cyano, or pyridyl which is unsubstituted or mono- to disubstituted, independently, by C1-C4alkyl, C1-C4alkoxy, halogen, C1-C2haloalkyl having 1 to 3 halogen atoms, nitro or cyano; R4 is C1-C4alkyl, phenyl, or R3 and R4 together with the nitrogen atom to which they are bonded form a saturated or unsaturated 5- to 7-membered ring which is unsubstituted or substituted by C1-C4alkyl and which can have 1 to 3 additional hetero atoms selected from amongst N, O and S, and in which the substituents Z, B, D and n are as defined in the present publication, are pesticidal active ingredients. They can be used for pest control, in particular as microbicides, insecticides and acaricides in agriculture, horticulture and in the hygiene sector.
Abstract:
Herstellung von O-substituierten Hydroxylaminen (I) H₂N-O-CH₂-R (I) (R = H, org. Rest) und deren Salze, durch Umsetzung eines cyclischen Imidethers II einer 1,4- oder 1,5-Dicarbonsäure, der eine Ethergruppierung -O-CH₂-R enthält, mit einer basischen Verbindung, indem man als basische Verbindung einen primären aliphatischen Aminoalkohol III verwendet und die Verbindung I gegebenenfalls in ihre Salze überführt.
Abstract translation:O-取代的羟胺(I)... H 2 N-O-CH 2 -R(I)...(R = H,有机基)及其盐通过使1,4-亚氨基或1,5- 二羧酸,其含有醚基团-O-CH2-R与碱性化合物,所用的碱性化合物是伯脂肪族氨基醇III,化合物I如果需要,转化为其盐。